Netweb Technologies India Ltd
BSE:543945
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Netweb Technologies India Ltd
BSE:543945
|
IN |
|
Citius Pharmaceuticals Inc
F:47N
|
US |
|
P
|
Patterson-UTI Energy Inc
SWB:PE1
|
US |
|
D
|
Dermapharm Holding SE
XBER:DMP
|
DE |
|
M
|
Medallion Financial Corp
F:MD5
|
US |
Wall St Price Targets
NETWEB Price Targets Summary
Netweb Technologies India Ltd
According to Wall Street analysts, the average 1-year price target for NETWEB is 4 392.53 INR with a low forecast of 4 152.45 INR and a high forecast of 4 726.54 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NETWEB's stock price target?
Price Target
4 392.53
INR
According to Wall Street analysts, the average 1-year price target for NETWEB is 4 392.53 INR with a low forecast of 4 152.45 INR and a high forecast of 4 726.54 INR.
What is the Revenue forecast for Netweb Technologies India Ltd?
Projected CAGR
29%
Over the last 5 years, the compound annual growth rate for Revenue has been 73%. The projected CAGR for the next 3 years is 29%.
What is the Operating Income forecast for Netweb Technologies India Ltd?
Projected CAGR
38%
Over the last 5 years, the compound annual growth rate for Operating Income has been 84%. The projected CAGR for the next 3 years is 38%.
What is the Pre-Tax Income forecast for Netweb Technologies India Ltd?
Projected CAGR
41%
Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 90%. The projected CAGR for the next 2 years is 41%.
What is the Net Income forecast for Netweb Technologies India Ltd?
Projected CAGR
36%
Over the last 5 years, the compound annual growth rate for Net Income has been 90%. The projected CAGR for the next 3 years is 36%.
